谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

PD-L1 As a Biomarker for the Efficacy of Durvalumab in Stage III EGFR Mutant NSCLC

Insu Kim,Sun Ha Choi,Shin Yup Lee,Seung Soo Yoo,Ji Eun Park,Kyeong-Cheol Shin,Jong Geol Jang,Kyung Soo Hong,Yong Shik Kwon,Sun Hyo Park,Keum-Ju Choi,Chi Young Jung,Mi-Hyun Kim,Soo Han Kim,Hee Yun Seol,Jehun Kim, Jin-Han Park,Tae Hoon Kim,Jung Seop Eom,June Hong Ahn

ANTICANCER RESEARCH（2024）

引用 0|浏览10
关键词
NSCLC,EGFR,PD-L1,durvalumab
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要